Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Overview of vitamin K

Sassan Pazirandeh, MD
David L Burns, MD
Section Editors
Timothy O Lipman, MD
Kathleen J Motil, MD, PhD
Deputy Editor
Alison G Hoppin, MD


Vitamins are a number of chemically unrelated families of organic substances that cannot be synthesized by humans but need to be ingested in the diet in small quantities to prevent disorders of metabolism. They are divided into water-soluble and fat-soluble vitamins (table 1).

More than 50 years ago, Henrik Dam of Denmark discovered an "antihemorrhagic factor" that was capable of reversing dietary-induced bleeding disorders in chicks [1]. The name "K" comes from the German/Danish word koagulationsvitamin (clotting vitamin) [2].

In 1930, vitamin K was first isolated by Doisy and his colleagues, as well as by Dam, from alfalfa sprouts [3]. Until the 1980s, when chromatographic techniques were used, the mainstay of vitamin K isolation was through using chick bioassay [2].

This topic review will focus on vitamin K. Overviews of the other fat-soluble vitamins, minerals and water-soluble vitamins are available elsewhere. (See "Overview of vitamin A" and "Overview of vitamin D" and "Overview of vitamin E" and "Overview of dietary trace minerals" and "Overview of water-soluble vitamins" and "Vitamin supplementation in disease prevention".)


Dietary vitamin K1 (phylloquinone or phytonadione) is found in green vegetables like spinach and broccoli (table 2) [4]. Gut micro-flora synthesizes vitamin K2 (menaquinones, including menatetrenone), which provides a portion of the dietary requirement of vitamin K [4]. Vitamin K2 has approximately 60 percent of the activity of vitamin K1, by weight, but bioavailability of both forms varies substantially depending on other intraluminal nutrients [5].


Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Sep 2016. | This topic last updated: Apr 13, 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
  1. Dam H. The antihemorrhagic vitamin of the chick: Occurrence and chemical nature. Nature 1935; 135:652.
  2. Vermeer C, Schurgers LJ. A comprehensive review of vitamin K and vitamin K antagonists. Hematol Oncol Clin North Am 2000; 14:339.
  3. Dam H, Geiger A, Glavind J, et al. olierung des Vitamins K in hochgereinigter Form. Helv Chim Acta 1939; 22:310.
  4. Furie B, Bouchard BA, Furie BC. Vitamin K-dependent biosynthesis of gamma-carboxyglutamic acid. Blood 1999; 93:1798.
  5. American Academy of Pediatrics. Fat-soluble vitamins. In: Pediatric Nutrition, 7th ed, Kleinman RE, Greer FR. (Eds), American Academy of Pediatrics, Elk Grove Village 2011. p.461.
  6. Shearer MJ. Vitamin K. Lancet 1995; 345:229.
  7. Furie B, Furie BC. Molecular basis of vitamin K-dependent gamma-carboxylation. Blood 1990; 75:1753.
  8. Davie EW. Biochemical and molecular aspects of the coagulation cascade. Thromb Haemost 1995; 74:1.
  9. Fair DS, Marlar RA, Levin EG. Human endothelial cells synthesize protein S. Blood 1986; 67:1168.
  10. Cushman M, Booth SL, Possidente CJ, et al. The association of vitamin K status with warfarin sensitivity at the onset of treatment. Br J Haematol 2001; 112:572.
  11. Hooper CA, Haney BB, Stone HH. Gastrointestinal bleeding due to vitamin K deficiency in patients on parenteral cefamandole. Lancet 1980; 1:39.
  12. Shearer MJ, Bechtold H, Andrassy K, et al. Mechanism of cephalosporin-induced hypoprothrombinemia: relation to cephalosporin side chain, vitamin K metabolism, and vitamin K status. J Clin Pharmacol 1988; 28:88.
  13. Light RF, Alscher RP, Frey CN. VITAMIN A TOXICITY AND HYPOPROTHROMBINEMIA. Science 1944; 100:225.
  14. Smith FR, Goodman DS. Vitamin A transport in human vitamin A toxicity. N Engl J Med 1976; 294:805.
  15. Bettger WJ, Jones JP, Olson RE. Effect of alpha-tocopherol and alpha-tocopherolquinone on vitamin K-dependent carboxylation in the rat. Fed Proc 1982; 41:344.
  16. Volpe JJ. Intracranial hemorrhage in early infancy--renewed importance of vitamin K deficiency. Pediatr Neurol 2014; 50:545.
  17. Miyasaka M, Nosaka S, Sakai H, et al. Vitamin K deficiency bleeding with intracranial hemorrhage: focus on secondary form. Emerg Radiol 2007; 14:323.
  18. Notes from the field: Late vitamin K deficiency bleeding in infants whose parents declined Vitamin K prophylaxis — Tennessee, 2013. MMWR Morb Mortal Wkly Rep 2013; 62:901.
  19. Schulte R, Jordan LC, Morad A, et al. Rise in late onset vitamin K deficiency bleeding in young infants because of omission or refusal of prophylaxis at birth. Pediatr Neurol 2014; 50:564.
  20. Shearer MJ. Vitamin K deficiency bleeding (VKDB) in early infancy. Blood Rev 2009; 23:49.
  21. Carpenter SL, Abshire TC, Anderst JD, Section on Hematology/Oncology and Committee on Child Abuse and Neglect of the American Academy of Pediatrics. Evaluating for suspected child abuse: conditions that predispose to bleeding. Pediatrics 2013; 131:e1357.
  22. Elalfy MS, Elagouza IA, Ibrahim FA, et al. Intracranial haemorrhage is linked to late onset vitamin K deficiency in infants aged 2-24 weeks. Acta Paediatr 2014; 103:e273.
  23. Olson R. Vitamin K. In: Modern Nutrition in Health and Disease, Shils M, Olson J, Shike M, et al (Eds), Lippincott, Philadelphia 2000. p.363.
  24. Motohara K, Endo F, Matsuda I. Effect of vitamin K administration on acarboxy prothrombin (PIVKA-II) levels in newborns. Lancet 1985; 2:242.
  25. American Academy of Pediatrics. Committee statement, Committee on Nutrition. Vitamin K supplementation for infants receiving milk substitute infant formulas and for those with fat malabsorption. Pediatrics 1971; 48:483.
  26. McLaren D. Clinical manifestations of human vitamin and mineral disorders. In: Modern Nutrition in Health and Disease, Shils M, Olson J, Shike M, et al (Eds), Lippincott, Philadelphia 2000. p.485.
  27. Chawla D, Deorari AK, Saxena R, et al. Vitamin K1 versus vitamin K3 for prevention of subclinical vitamin deficiency: a randomized controlled trial. Indian Pediatr 2007; 44:817.
  28. Food and Nutrition Board of the Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc (2000). National Academies Press, Washington DC, 2000. p. 162-196 http://books.nap.edu/openbook.php?isbn=0309072794 (Accessed on July 23, 2007).
  29. Schurgers LJ, Shearer MJ, Hamulyák K, et al. Effect of vitamin K intake on the stability of oral anticoagulant treatment: dose-response relationships in healthy subjects. Blood 2004; 104:2682.
  30. Blanchard RA, Furie BC, Kruger SF, et al. Immunoassays of human prothrombin species which correlate with functional coagulant activities. J Lab Clin Med 1983; 101:242.
  31. Greer FR. Are breast-fed infants vitamin K deficient? Adv Exp Med Biol 2001; 501:391.
  32. Greer FR, Marshall SP, Foley AL, Suttie JW. Improving the vitamin K status of breastfeeding infants with maternal vitamin K supplements. Pediatrics 1997; 99:88.